Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$3.78 - $5.18 $971 - $1,331
-257 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$4.1 - $5.33 $64,546 - $83,910
-15,743 Reduced 98.39%
257 $1,000
Q2 2020

Aug 07, 2020

BUY
$3.76 - $8.01 $60,160 - $128,160
16,000 New
16,000 $94,000
Q2 2019

Aug 09, 2019

SELL
$7.08 - $10.6 $39,648 - $59,360
-5,600 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$7.67 - $9.96 $58,292 - $75,696
-7,600 Reduced 57.58%
5,600 $45,000
Q2 2018

Aug 10, 2018

BUY
$9.11 - $28.88 $120,251 - $381,216
13,200 New
13,200 $154,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0

About CATALYST BIOSCIENCES, INC.


  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.